Treatment Protocol of Children With Philadelphia Chromosome Negative High Risk Acute Lymphoblastic Leukemia

NCT01990807 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Childhood Acute Lymphoblastic Leukemia
Philadelphia Chromosome, Ph^1^, Absent
B-cell Childhood Acute Lymphoblastic Leukemia

Interventions

DRUG: Idarubicin(IDA)

Sponsor

Chinese Academy of Medical Sciences